X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19682) 19682
Newsletter (169) 169
Newspaper Article (133) 133
Book Chapter (56) 56
Magazine Article (55) 55
Book / eBook (17) 17
Trade Publication Article (8) 8
Dissertation (6) 6
Government Document (5) 5
Conference Proceeding (3) 3
Book Review (2) 2
Report (2) 2
Journal / eJournal (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17252) 17252
female (11682) 11682
male (9800) 9800
middle aged (8706) 8706
aged (7399) 7399
adult (7189) 7189
oncology (5978) 5978
skin neoplasms - pathology (5685) 5685
melanoma (5408) 5408
cancer (5306) 5306
skin neoplasms - mortality (4565) 4565
prognosis (4283) 4283
dermatology (3845) 3845
skin cancer (3799) 3799
aged, 80 and over (3538) 3538
melanoma - mortality (3524) 3524
melanoma - pathology (3271) 3271
risk factors (3137) 3137
skin (3006) 3006
surgery (2788) 2788
retrospective studies (2665) 2665
skin and connective tissue diseases (2588) 2588
mortality (2526) 2526
research (2418) 2418
metastasis (2350) 2350
tumors (2281) 2281
adolescent (2266) 2266
breast cancer (2208) 2208
survival (2206) 2206
neoplasm staging (2199) 2199
care and treatment (2045) 2045
skin neoplasms - epidemiology (2036) 2036
survival rate (1982) 1982
treatment outcome (1966) 1966
animals (1917) 1917
analysis (1855) 1855
diagnosis (1855) 1855
health aspects (1813) 1813
skin neoplasms - diagnosis (1778) 1778
follow-up studies (1773) 1773
risk (1713) 1713
skin neoplasms - surgery (1706) 1706
incidence (1703) 1703
survival analysis (1672) 1672
young adult (1610) 1610
malignant-melanoma (1595) 1595
skin neoplasms - therapy (1556) 1556
epidemiology (1431) 1431
chemotherapy (1387) 1387
research article (1351) 1351
patients (1310) 1310
skin neoplasms - drug therapy (1295) 1295
disease-free survival (1292) 1292
child (1266) 1266
melanoma - epidemiology (1264) 1264
time factors (1252) 1252
melanoma - surgery (1247) 1247
lymphatic metastasis (1235) 1235
immunohistochemistry (1229) 1229
cutaneous melanoma (1220) 1220
expression (1219) 1219
medicine (1215) 1215
pathology (1199) 1199
medicine & public health (1166) 1166
skin neoplasms - etiology (1152) 1152
mice (1126) 1126
melanoma - diagnosis (1101) 1101
biopsy (1093) 1093
breast neoplasms - pathology (1086) 1086
melanoma - secondary (1036) 1036
studies (1031) 1031
carcinoma (1017) 1017
therapy (1004) 1004
cancer therapies (997) 997
kaplan-meier estimate (993) 993
skin neoplasms - genetics (993) 993
neoplasms (980) 980
medical prognosis (979) 979
skin neoplasms - prevention & control (968) 968
cell line, tumor (965) 965
mutation (963) 963
cohort studies (959) 959
squamous cell carcinoma (959) 959
development and progression (930) 930
genetic aspects (919) 919
age factors (909) 909
melanoma - drug therapy (895) 895
metastases (888) 888
prevention (883) 883
melanoma - therapy (881) 881
neoplasm metastasis (881) 881
risk assessment (880) 880
gene expression (846) 846
medical research (841) 841
apoptosis (839) 839
radiotherapy (829) 829
public, environmental & occupational health (826) 826
prospective studies (814) 814
cell biology (813) 813
oncology, experimental (811) 811
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19432) 19432
German (263) 263
French (128) 128
Russian (88) 88
Spanish (59) 59
Japanese (44) 44
Italian (41) 41
Polish (35) 35
Danish (19) 19
Dutch (18) 18
Swedish (15) 15
Portuguese (11) 11
Chinese (10) 10
Czech (7) 7
Finnish (5) 5
Hungarian (5) 5
Norwegian (5) 5
Serbian (5) 5
Turkish (5) 5
Hebrew (4) 4
Korean (3) 3
Croatian (2) 2
Ukrainian (2) 2
Arabic (1) 1
Persian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of oncology, ISSN 0923-7534, 2003, Volume 14, Issue 5, pp. v61 - v118
EUROCARE-3 analysed the survival of 1815584 adult cancer patients diagnosed from 1990 to 1994 in 22 European countries. The results are reported in tables, one... 
international comparison | Europe | population-based cancer registries | age-standardised relative survival | cancer survival | Cancer survival | Population-based cancer registries | Age-standardised relative survival | International comparison | PROSTATE | ADULT PATIENTS | PROGNOSIS | STAGE | TESTICULAR CANCER | TRENDS | TUMORS | BREAST-CANCER | LUNG-CANCER | ONCOLOGY | Urologic Neoplasms - epidemiology | Testicular Neoplasms - mortality | Digestive System Neoplasms - mortality | Lung Neoplasms - mortality | Hematologic Neoplasms - mortality | Humans | Thyroid Neoplasms - epidemiology | Male | Neoplasms - diagnosis | Testicular Neoplasms - epidemiology | Hematologic Neoplasms - epidemiology | Genital Neoplasms, Female - epidemiology | Registries - statistics & numerical data | Skin Neoplasms - mortality | Head and Neck Neoplasms - epidemiology | Female | Brain Neoplasms - mortality | Breast Neoplasms - epidemiology | Digestive System Neoplasms - epidemiology | Thyroid Neoplasms - mortality | Urologic Neoplasms - mortality | Europe - epidemiology | Neoplasms - mortality | Survival Rate | Skin Neoplasms - epidemiology | Prostatic Neoplasms - mortality | Prostatic Neoplasms - epidemiology | Genital Neoplasms, Female - mortality | Lung Neoplasms - epidemiology | Sex Factors | Survival Analysis | Breast Neoplasms - mortality | Head and Neck Neoplasms - mortality | Neoplasms - epidemiology | Brain Neoplasms - epidemiology
Journal Article
Journal Article
Epidemiology, ISSN 1044-3983, 01/2018, Volume 29, Issue 1, pp. 31 - 40
Journal Article
American Journal of Pathology, ISSN 0002-9440, 2010, Volume 177, Issue 4, pp. 1647 - 1656
Phosphatase and tensin homolog (PTEN) is a key modulator of trastuzumab sensitivity in HER2-overexpressing breast cancer. Because PTEN opposes the downstream... 
ADJUVANT CHEMOTHERAPY | INHIBITION | THERAPY | PROTEIN | HUMAN-BREAST-CANCER | PATHWAY | MUTATIONS | PATHOLOGY | RECEPTORS | TRASTUZUMAB RESISTANCE | EXPRESSION | Lung Neoplasms - drug therapy | Receptors, Estrogen - metabolism | Receptor, ErbB-2 - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Immunoenzyme Techniques | Receptors, Progesterone - metabolism | Young Adult | Carcinoma, Ductal, Breast - drug therapy | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Proto-Oncogene Proteins c-akt - metabolism | Carcinoma, Ductal, Breast - metabolism | PTEN Phosphohydrolase - genetics | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | Survival Rate | Lymphatic Metastasis | Brain Neoplasms - drug therapy | Mutation - genetics | Breast Neoplasms - drug therapy | Class I Phosphatidylinositol 3-Kinases | Carcinoma, Lobular - metabolism | Trastuzumab | Bone Neoplasms - mortality | Phosphorylation | Prognosis | Receptor, ErbB-2 - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Liver Neoplasms - mortality | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Brain Neoplasms - secondary | In Situ Hybridization | Lung Neoplasms - secondary | Adult | Female | Bone Neoplasms - drug therapy | Neoplasm Invasiveness | Liver Neoplasms - drug therapy | PTEN Phosphohydrolase - metabolism | Phosphatidylinositol 3-Kinases - genetics | Breast Neoplasms - mortality | Aged | Carcinoma, Lobular - drug therapy | Regular
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 2016, Volume 66, Issue 4, pp. 271 - 289
The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population. For... 
prevalence | survivorship | treatment patterns | statistics | LYMPH-NODE DISSECTION | ADJUVANT CHEMOTHERAPY | SELECTIVE BLADDER PRESERVATION | LONG-TERM SURVIVORS | BREAST-CONSERVING THERAPY | METASTATIC PROSTATE-CANCER | ANDROGEN-DEPRIVATION THERAPY | ONCOLOGY | COLORECTAL-CANCER | CARDIOVASCULAR-DISEASE | QUALITY-OF-LIFE | Uterine Neoplasms - therapy | United States - epidemiology | Prevalence | Humans | Middle Aged | Survivors - statistics & numerical data | Child, Preschool | National Cancer Institute (U.S.) | Infant | Male | Neoplasms - diagnosis | Incidence | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | American Cancer Society | Neoplasms - therapy | Skin Neoplasms - mortality | Aged, 80 and over | Uterine Neoplasms - mortality | Adult | Female | Registries | Child | Infant, Newborn | Colonic Neoplasms - therapy | Colonic Neoplasms - mortality | Skin Neoplasms - therapy | Risk Factors | Neoplasms - mortality | Survival Rate | Evidence-Based Medicine | Prostatic Neoplasms - mortality | Adolescent | Breast Neoplasms - mortality | Aged | Melanoma - therapy | Neoplasms - epidemiology | Melanoma - mortality | Care and treatment | Management | Primary health care | Analysis | Public health | Cancer | Survivor | Oncology | Family medical history | Disease management | Medical diagnosis | Medical statistics | Primary care
Journal Article
European Journal of Cancer Prevention, ISSN 0959-8278, 2015, Volume 24, Issue 2, pp. 150 - 154
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 49, Issue 9, pp. 2187 - 2198
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 92, Issue 1, pp. 130 - 137
Purpose To report the long-term outcome and patterns of relapse of a large cohort of marginal zone lymphoma (MZL) patients treated with curative-intent... 
Radiology | Hematology, Oncology and Palliative Medicine | TRIAL | MULTICENTER | ONCOLOGY | TISSUE LYMPHOMA | RADIOTHERAPY | MALT LYMPHOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | STOMACH | Recurrence | Lymphoma, B-Cell, Marginal Zone - radiotherapy | Age Factors | Follow-Up Studies | Skin Neoplasms - radiotherapy | Humans | Middle Aged | Male | Stomach Neoplasms - pathology | Cause of Death | Lymphoma, B-Cell, Marginal Zone - mortality | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Lymphoma, B-Cell, Marginal Zone - pathology | Retrospective Studies | Neoplasms, Radiation-Induced | Orbital Neoplasms - radiotherapy | Skin Neoplasms - pathology | Stomach Neoplasms - radiotherapy | Orbital Neoplasms - pathology | Treatment Outcome | Head and Neck Neoplasms - pathology | Neoplasms, Second Primary - etiology | Disease-Free Survival | Head and Neck Neoplasms - radiotherapy | Breast Neoplasms - radiotherapy | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Aged | Head and Neck Neoplasms - mortality | Orbital Neoplasms - mortality | Stomach Neoplasms - mortality | Antimitotic agents | Sects | Care and treatment | Radiation | Radiotherapy | Antineoplastic agents | Cancer | Tumors | REVIEWS | HEAD | PATIENTS | MAMMARY GLANDS | THYROID | DEATH | RADIATION DOSES | SYMPTOMS | PATHOLOGY | LYMPHOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | SKIN | HAZARDS
Journal Article
Advances in Chronic Kidney Disease, ISSN 1548-5595, 2014, Volume 21, Issue 1, pp. 106 - 113
..., we will review the incidence of cancer in kidney transplant recipients (KTRs), mechanisms for their increased incidence, and the effect on mortality. We will also br... 
Nephrology | Immunosuppression | Malignancy | Kidney transplant | Cancer screening | AZATHIOPRINE | RISK | HUMAN-PAPILLOMAVIRUS | RECIPIENTS | MAMMOGRAPHY | CIGARETTE-SMOKING | NONMELANOMA SKIN-CANCER | UROLOGY & NEPHROLOGY | INFECTION | IMMUNOSUPPRESSIVE DRUGS | EPSTEIN-BARR-VIRUS | Kidney Neoplasms - epidemiology | Breast Neoplasms - immunology | Humans | Uterine Cervical Neoplasms - epidemiology | Kidney Neoplasms - immunology | Lymphoproliferative Disorders - immunology | Neoplasms - diagnosis | Kidney Transplantation - statistics & numerical data | Carcinoma, Renal Cell - immunology | Colorectal Neoplasms - diagnosis | Kidney Neoplasms - diagnosis | Skin Neoplasms - diagnosis | Female | Anus Neoplasms - epidemiology | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | Kidney Failure, Chronic - surgery | Uterine Cervical Neoplasms - diagnosis | Skin Neoplasms - immunology | Early Detection of Cancer | Uterine Cervical Neoplasms - immunology | Skin Neoplasms - epidemiology | Lymphoproliferative Disorders - epidemiology | Anus Neoplasms - diagnosis | Carcinoma, Renal Cell - epidemiology | Anus Neoplasms - immunology | Colorectal Neoplasms - immunology | Lymphoproliferative Disorders - diagnosis | Neoplasms - immunology | Carcinoma, Renal Cell - diagnosis | Immunosuppressive Agents - adverse effects | Breast Neoplasms - diagnosis | Immunocompromised Host | Neoplasms - epidemiology
Journal Article
Surgery today (Tokyo, Japan), ISSN 1436-2813, 2012, Volume 42, Issue 8, pp. 752 - 758
The results and outcomes of surgical resection for esophageal carcinoma have improved remarkably in recent years; however, recurrence still frequently... 
Recurrence | Medicine & Public Health | Cardiac Surgery | Surgery | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | Surgical Oncology | Esophageal cancer | LYMPH-NODE DISSECTION | 2-FIELD | POSITRON-EMISSION-TOMOGRAPHY | EXTENDED RADICAL ESOPHAGECTOMY | THORACIC ESOPHAGUS | DISEASE | SQUAMOUS-CELL CARCINOMA | CURATIVE RESECTION | 3-FIELD LYMPHADENECTOMY | Bone Neoplasms - mortality | Bone Neoplasms - therapy | Follow-Up Studies | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - pathology | Humans | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Esophageal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Time Factors | Esophageal Neoplasms - surgery | Skin Neoplasms - mortality | Skin Neoplasms - diagnosis | Esophageal Neoplasms - mortality | Retrospective Studies | Liver Neoplasms - secondary | Bone Neoplasms - diagnosis | Skin Neoplasms - therapy | Neoplasm Recurrence, Local - therapy | Kaplan-Meier Estimate | Esophagectomy | Survival Rate | Treatment Outcome | Combined Modality Therapy | Lung Neoplasms - therapy | Lymphatic Metastasis | Neoplasm Recurrence, Local - diagnosis | Liver Neoplasms - diagnosis | Skin Neoplasms - secondary | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - diagnosis | Neoplasm Staging | Neck Dissection
Journal Article